1. Home
  2. ILMN

ILMN

Illumina Inc.

Logo Illumina Inc.

Health Care

Medical Specialities

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Founded: 1998 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 18.8B IPO Year: 2000
Target Price: $174.20 AVG Volume (30 days): 1.7M
Analyst Decision: Buy Number of Analysts: 18
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.34 EPS Growth: N/A
52 Week Low/High: $89.00 - $232.23 Next Earning Date: 05-02-2024
Revenue: $4,504,000,000 Revenue Growth: -1.75%
Revenue Growth (this year): 2.04% Revenue Growth (next year): 7.96%

Share on Social Networks: